Rock Springs Capital Management’s Theravance Biopharma TBPH Stock Holding History

Rock Springs Capital Management’s Portfolio TBPH Stock Details TBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-208,771	Closed	-$3.91M	–	107
2025 Q4	$3.91M	Buy	+208,771	New	+$3.46M	0.2%	80
2021 Q4	–	Sell	-687,500	Closed	-$5.09M	–	147
2021 Q3	$5.09M	Hold	687,500	–	–	0.11%	126
2021 Q2	$9.98M	Buy	687,500 +4,900	+0.7%	+$92K	0.2%	114
2021 Q1	$13.9M	Buy	682,600 +4,400	+0.6%	+$83.6K	0.3%	91
2020 Q4	$12.1M	Sell	678,200 -145,818	-18%	-$2.62M	0.26%	105
2020 Q3	$12.2M	Sell	824,018 -4,200	-0.5%	-$78.7K	0.31%	89
2020 Q2	$17.4M	Buy	828,218 +78,218	+10%	+$2.01M	0.48%	70
2020 Q1	$17.3M	Buy	750,000 +94,800	+14%	+$2.37M	0.72%	51
2019 Q4	$17M	Buy	655,200 +105,200	+19%	+$2.04M	0.54%	67
2019 Q3	$10.7M	Hold	550,000	–	–	0.43%	74
2019 Q2	$8.98M	Hold	550,000	–	–	0.33%	83
2019 Q1	$12.5M	Hold	550,000	–	–	0.49%	70
2018 Q4	$14.1M	Hold	550,000	–	–	0.66%	49
2018 Q3	$18M	Sell	550,000 -102,600	-16%	-$2.8M	0.65%	53
2018 Q2	$14.8M	Hold	652,600	–	–	0.57%	67
2018 Q1	$15.8M	Hold	652,600	–	–	0.68%	55
2017 Q4	$18.2M	Buy	652,600 +8,200	+1%	+$243K	0.83%	40
2017 Q3	$22.1M	Buy	644,400 +44,400	+7%	+$1.45M	1.02%	29
2017 Q2	$23.9M	Hold	600,000	–	–	1.22%	22
2017 Q1	$22.1M	Hold	600,000	–	–	1.27%	26
2016 Q4	$19.1M	Hold	600,000	–	–	1.28%	25
2016 Q3	$21.7M	Sell	600,000 -100,000	-14%	-$2.78M	1.36%	24
2016 Q2	$15.9M	Buy	700,000 +49,500	+8%	+$1.07M	1.18%	25
2016 Q1	$12.2M	Buy	650,500 +5,500	+0.9%	+$90K	1.03%	30
2015 Q4	$10.6M	Buy	645,000 +42,500	+7%	+$674K	0.8%	43
2015 Q3	$6.62M	Buy	602,500 +127,500	+27%	+$1.62M	0.54%	66
2015 Q2	$6.18M	Buy	475,000 +101,000	+27%	+$1.57M	0.45%	77
2015 Q1	$6.49M	Buy	374,000 +84,000	+29%	+$1.54M	0.61%	57
2014 Q4	$4.33M	Buy	290,000 +134,500	+86%	+$2.34M	0.51%	61
2014 Q3	$3.58M	Buy	155,500 +105,500	+211%	+$3.06M	0.55%	56
2014 Q2	$1.59M	Buy	+50,000	New	+$1.51M	0.29%	74